{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:59:24Z","timestamp":1791917964903,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":912,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"HHS NIH National Institute of Environmental Health Sciences (NIEHS)","doi-asserted-by":"publisher","award":["Z01 ES025034"],"award-info":[{"award-number":["Z01 ES025034"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung (SNF)","doi-asserted-by":"publisher","award":["PDFMP3_127330"],"award-info":[{"award-number":["PDFMP3_127330"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1074\/jbc.ra117.000298","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T16:51:43Z","timestamp":1514998303000},"page":"3281-3292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia"],"prefix":"10.1016","volume":"293","author":[{"given":"Matthew L.","family":"Edin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behin Gholipour","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artiom","family":"Gruzdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan P.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred B.","family":"Lih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Samuel J.","family":"Arbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohanit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette C.","family":"Orjuela Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alyce","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"DeGraff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Hoopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Arand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA117.000298_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.RA117.000298_bib3","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1074\/jbc.RA117.000298_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000237390.92932.37","article-title":"Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function","volume":"99","author":"Seubert","year":"2006","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA117.000298_bib5","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00927.2005","article-title":"Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: Implications for soluble epoxide hydrolase inhibition","volume":"290","author":"Larsen","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1074\/jbc.RA117.000298_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1074\/jbc.RA117.000298_bib7","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M024448","article-title":"EH3 (ABHD9): The first member of a new epoxide hydrolase family with high activity for fatty acid epoxides","volume":"53","author":"Decker","year":"2012","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.000298_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","article-title":"Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism","volume":"163","author":"Marowsky","year":"2009","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.RA117.000298_bib9","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00204-017-2060-4","article-title":"Beyond detoxification: A role for mouse mEH in the hepatic metabolism of endogenous lipids","volume":"91","author":"Marowsky","year":"2017","journal-title":"Arch. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib10","doi-asserted-by":"crossref","first-page":"e0175348","DOI":"10.1371\/journal.pone.0175348","article-title":"Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice","volume":"12","author":"Hoopes","year":"2017","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA117.000298_bib11","doi-asserted-by":"crossref","first-page":"23963","DOI":"10.1074\/jbc.274.34.23963","article-title":"Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene","volume":"274","author":"Miyata","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000298_bib12","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000298_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-2952(80)90518-3","article-title":"Distribution and properties of a mammalian soluble epoxide hydrase","volume":"29","author":"Gill","year":"1980","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.RA117.000298_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/291167a0","article-title":"Epoxide hydrolase activity in the mitochondrial fraction of mouse liver","volume":"291","author":"Gill","year":"1981","journal-title":"Nature"},{"key":"10.1074\/jbc.RA117.000298_bib15","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/S0021-9258(19)69582-7","article-title":"Cytosolic and microsomal epoxide hydrolases are immunologically distinguishable from each other in the rat and mouse","volume":"256","author":"Guenthner","year":"1981","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000298_bib16","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids","volume":"51","author":"Morisseau","year":"2010","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.000298_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"10.1074\/jbc.RA117.000298_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.07.071","article-title":"Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease","volume":"571","author":"V\u00e1clav\u00edkov\u00e1","year":"2015","journal-title":"Gene"},{"key":"10.1074\/jbc.RA117.000298_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0003-9861(02)00079-6","article-title":"Activation of microsomal epoxide hydrolase by interaction with cytochromes P450: kinetic analysis of the association and substrate-specific activation of epoxide hydrolase function","volume":"402","author":"Taura Ki","year":"2002","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.RA117.000298_bib20","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1016\/S0021-9258(19)69171-4","article-title":"Differences in the functional interaction of two purified cytochrome P-450 isozymes with epoxide hydrolase","volume":"256","author":"Kaminsky","year":"1981","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000298_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0009-2797(01)00176-4","article-title":"Physiological modeling of butadiene disposition in mice and rats","volume":"135\u2013136","author":"Kohn","year":"2001","journal-title":"Chem. Biol. Interact"},{"key":"10.1074\/jbc.RA117.000298_bib22","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.11-188300","article-title":"Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart","volume":"25","author":"Edin","year":"2011","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA117.000298_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1194\/jlr.M049718","article-title":"Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation","volume":"55","author":"Morisseau","year":"2014","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.000298_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/tx9500944","article-title":"Simulation of human benzo[a]pyrene metabolism deduced from the analysis of individual kinetic steps in recombinant yeast","volume":"9","author":"Gautier","year":"1996","journal-title":"Chem. Res. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1080\/15287394.2010.516240","article-title":"Metabolism and toxicity of styrene in microsomal epoxide hydrolase-deficient mice","volume":"73","author":"Carlson","year":"2010","journal-title":"J. Toxicol. Environ. Health Part A"},{"key":"10.1074\/jbc.RA117.000298_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00343278","article-title":"Inactivation of electrophilic metabolites by glutathione S-transferases and limitation of the system due to subcellular localization","volume":"39","author":"Glatt","year":"1977","journal-title":"Arch. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF00296975","article-title":"Significance of various enzymes in the control of reactive metabolites","volume":"60","author":"Oesch","year":"1987","journal-title":"Arch. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib28","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0006-2952(81)90230-6","article-title":"Epoxide hydrolase activity in the mitochondrial and submitochondrial fractions of mouse liver","volume":"30","author":"Gill","year":"1981","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.RA117.000298_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/tx2004085","article-title":"Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer","volume":"25","author":"Dansette","year":"2012","journal-title":"Chem. Res. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10565-011-9190-x","article-title":"Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells","volume":"27","author":"Abukhashim","year":"2011","journal-title":"Cell Biol. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20131494","article-title":"Muller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid","volume":"211","author":"Hu","year":"2014","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA117.000298_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1172\/JCI58128","article-title":"Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice","volume":"122","author":"Panigrahy","year":"2012","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000298_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.114.214254","article-title":"The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R\/S-enantiomer and require the G(s) protein","volume":"350","author":"Ding","year":"2014","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.RA117.000298_bib34","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1073\/pnas.0437724100","article-title":"The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity","volume":"100","author":"Newman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.000298_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00204-009-0416-0","article-title":"Mammalian epoxide hydrolases in xenobiotic metabolism and signalling","volume":"83","author":"Decker","year":"2009","journal-title":"Arch. Toxicol"},{"key":"10.1074\/jbc.RA117.000298_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/FJC.0b013e3181c37d69","article-title":"Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury","volume":"55","author":"Chaudhary","year":"2010","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"10.1074\/jbc.RA117.000298_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","article-title":"Epoxyeicosatrienoic acids and cardioprotection: The road to translation","volume":"74","author":"Oni-Orisan","year":"2014","journal-title":"J. Mol. Cell. Cardiol"},{"key":"10.1074\/jbc.RA117.000298_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol. Ther"},{"key":"10.1074\/jbc.RA117.000298_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0091270010397049","article-title":"Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects","volume":"52","author":"Chen","year":"2012","journal-title":"J. Clin. Pharmacol"},{"key":"10.1074\/jbc.RA117.000298_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.RA117.000298_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1074248409358408","article-title":"Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection","volume":"15","author":"Nithipatikom","year":"2010","journal-title":"J. Cardiovasc. Pharmacol. Ther"},{"key":"10.1074\/jbc.RA117.000298_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA117.000298_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prostaglandins.2011.09.001","article-title":"CYP-eicosanoids\u2014a new link between omega-3 fatty acids and cardiac disease?","volume":"96","author":"Westphal","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.RA117.000298_bib44","first-page":"H2098","article-title":"Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids","volume":"277","author":"Weintraub","year":"1999","journal-title":"Am. J. Physiol"},{"key":"10.1074\/jbc.RA117.000298_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-2275(20)32075-7","article-title":"Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts","volume":"41","author":"Fang","year":"2000","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.000298_bib46","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1074\/jbc.M011761200","article-title":"Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition","volume":"276","author":"Fang","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA117.000298_bib47","doi-asserted-by":"crossref","first-page":"H2306","DOI":"10.1152\/ajpheart.00448.2002","article-title":"Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide","volume":"283","author":"Fang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1074\/jbc.RA117.000298_bib48","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/dmd.112.049429","article-title":"Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily","volume":"41","author":"Graves","year":"2013","journal-title":"Drug Metab. Dispos"},{"key":"10.1074\/jbc.RA117.000298_bib49","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/dmd.115.064139","article-title":"Quantitative polymerase chain reaction analysis of the mouse Cyp2j subfamily: Tissue distribution and regulation","volume":"43","author":"Graves","year":"2015","journal-title":"Drug Metab. Dispos"},{"key":"10.1074\/jbc.RA117.000298_bib50","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1007\/s00204-017-2072-0","article-title":"Evidence for a complex formation between CYP2J5 and mEH in living cells by FRET analysis of membrane protein interaction in the endoplasmic reticulum (FAMPIR)","volume":"91","author":"Orjuela Leon","year":"2017","journal-title":"Arch. Toxicol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820390633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820390633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA117.000298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T20:18:51Z","timestamp":1639685931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820390633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0021925820390633"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra117.000298","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732398008.793542637","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA117.000298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}